AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 31(6), 1982, pp. 1075-1079
Copyright © 1982 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cosgriff, T. M.
Right arrow Articles by Canfield, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cosgriff, T. M.
Right arrow Articles by Canfield, C. J.

Evaluation of the Antimalarial Activity of the Phenanthrenemethanol Halofantrine (WR 171,669)*

Thomas M. Cosgriff, Ellen F. Boudreau, Charles L. Pamplin, E. Brian Doberstyn{dagger}, Robert E. Desjardins{ddagger} AND Craig J. Canfield
Walter Reed Army Institute of Research, Washington, D.C. 20012

Abstract. Halofantrine (WR 171,669) was administered to 27 nonimmune subjects infected with the multi-drug resistant Vietnam Smith strain of Plasmodium falciparum. It was also administered to three other subjects, one infected with the Cambodian Buchanan strain of P. falciparum, and two with blood-induced infection with the Chesson strain of P. vivax. It cured infections with all three parasites. Against the highly chloroquine-resistant Smith strain, it was curative in single day treatment regimens. The drug was well tolerated and produced rapid clearance of parasitemia in every case.

Accepted for publication May 6, 1982.


* The subjects in these studies were United States Army personnel at the United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, as well as civilians from the Washington, DC area. The studies were governed by the principles, policies, and rules for medical volunteers as established by Army Regulation 70-25 and the Declaration of Helsinki.

The views of the authors do not purport to reflect the positions of the Department of the Army or the Department of Defense.


{dagger} Present address: World Health Organization, The Malaria Division, Ministry of Public Health, Devavesm Palace, Bangkok 2, Thailand.


{ddagger} Present address: Head, Anti-Infectives Section, Medical Department, Burroughs Wellcome Co., 3030 Cornwallis Road, Research Triangle Park, North Carolina 27709.




This article has been cited by other articles:


Home page
JRSMHome page
A. M Croft
A lesson learnt: the rise and fall of Lariam and Halfan
J R Soc Med, April 1, 2007; 100(4): 170 - 174.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Mbai, S. Rajamani, and C. T January
The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels
Cardiovasc Res, September 1, 2002; 55(4): 799 - 805.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American Society of Tropical Medicine and Hygiene.